I don't know what practical value there is in getting the hold lifted besides removing a stain on Cytodyn's reputation. That may help us get collaborators or not. It wouldn't impact our financial problems otherwise, as far as I can tell. I think it has been a bit of a distraction really.
What is of most value to us right now with the situation we are in is the ongoing trials by MD Anderson and Merck and Dr. Sasha at Oregon Health Sciences University. These are potential blockbuster trials but they take time. Is that what's causing Cytodyn to seeming be just sitting on their thumbs? Nothing else to do or can be done?
I still can't believe that there isn't some outfit out there that would love to get their hands on Leronlimab for some indication. Is there no one out there that would like a license to develop Leronlimab for just one indication and for a limited market? Or all indications in a limited market?
What is happening with MD Anderson and Merck and the combination trials with Keytruda?
What is of most value to us right now with the situation we are in is the ongoing trials by MD Anderson and Merck and Dr. Sasha at Oregon Health Sciences University. These are potential blockbuster trials but they take time. Is that what's causing Cytodyn to seeming be just sitting on their thumbs? Nothing else to do or can be done?
I still can't believe that there isn't some outfit out there that would love to get their hands on Leronlimab for some indication. Is there no one out there that would like a license to develop Leronlimab for just one indication and for a limited market? Or all indications in a limited market?
What is happening with MD Anderson and Merck and the combination trials with Keytruda?
6
